Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Prostatic Neoplasms 35Neoplasm Metastasis 10Recurrence 7Breast Neoplasms 5Carcinoma, Transitional Cell 4Stomach Neoplasms 3Neoplastic Cells, Circulating 3Metastatic Castration-resistant Prostate Cancer 3Carcinoma, Non-Small-Cell Lung 3Brain Neoplasms 3Urinary Bladder Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Ovarian Neoplasms 2Neoplasms 2Glioblastoma 2Carcinoma, Squamous Cell 2Thrombocytosis 1Testicular Neoplasms 1Prostatic Neoplasms, Castration-Resistant 1Prostate Cancer, Hereditary, 7 1Prostate Cancer Metastatic 1Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Penile Neoplasms 1Pancreatic Neoplasms 1Oligodendroglioma 1Nonseminomatous germ cell tumor 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1

Interventions

Mitotane 7Cisplatin 6pembrolizumab 5Etoposide 3Doxorubicin 3camrelizumab 2apatinib 2Specimen Handling 2Magnetic Resonance Spectroscopy 2Cytoreduction Surgical Procedures 2sodium thiosulfate 1iodophenyl metomidate 1fludarabine phosphate 1dostarlimab 1cemiplimab 1cabozantinib 1cabazitaxel 1antineoplaston AS 2-1 1antineoplaston A10 1Suramin 1Sunitinib 1Streptozocin 1Sorafenib 1Radiation 1Paclitaxel 1Observation 1Nivolumab 1Megestrol Acetate 1Lymph Node Excision 1Ipilimumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Adrenocortical Carcinoma × cabazitaxel × Clear all
NCT03257891 2018-04-11

CabACC

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

Phase 2 Unknown
25 enrolled
Endocrine

Adrenocortical Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡